Since all these molecules sharing SSAO inhibitory properties exhibited some anti-obesity effects, it was of utmost interest to check whether semicarbazide, the reference agent for inhibiting copper-containing oxidases, was unambiguously reported to reduce body weight and/or adiposity. Here, AOC3 is linked to obesity due to melanocortin 4 receptor deficiency.